Industry / United Kingdom
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
EMEA Approves First Pre-Pandemic Bird Flu Vaccine
May 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
The European Medicines Agency (EMEA) has given GlaxoSmithKline (GSK) approval to market its human avian-influenza vaccine Prepandrix. The licence will allow the company to negotiate money-spinning supply contracts with governments, NGOs and companies within the 27 EU member